Published: August 2025
Pages: 96
This ISPE Sustainability Guide is a foundational document that presents key principles and concepts to reinforce sustainable practices in the pharmaceutical industry, based on global and local guides, including existing regulations. Although intended for Small and Medium Sized Entreprises (SME) at the start of their sustainability journey, larger organizations may also use this Guide to support their sustainability strategy.
The main objectives of the Guide are to provide an overview of key environmental sustainability definitions, to develop a cohesive industry approach that integrates sustainability into existing pharmaceutical development, operations, quality and supply chain processes, and to provide guidance on the management of sustainability programs, including the use of metrics to measure performance.
Key concepts discussed include:
The intent is to guide the pharmaceutical industry toward a future where sustainable practices are embedded in every lifecycle stage of pharmaceutical development and production.
For the full list of contributors to this Guide see Guidance Document Teams
ISPE members located in nations with emerging economies* are eligible for a 50% discount on publications from the regular member price. To receive the discount, members must be logged in with their ISPE member account. Contact Member Services at ask@ispe.org for more information or if you have questions about your membership status or this discount program. Discounts do not apply to Accuris (formerly Techstreet) document downloads.
*Based on the World Bank's system for classifying national economies by GNI per capita. Includes low-income, lower middle-income, and upper middle-income economies. To learn more about the World Bank classification system, please click here. Currently includes the following nations, except where international sanctions apply: